Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib

Pulmonary pleomorphic carcinoma (PPC) is rare, and the response of patients to conventional chemotherapy is very poor. Here we present a patient with anaplastic lymphoma kinase (ALK)-rearranged advanced PPC treated with crizotinib. Computed tomography revealed a mass in the left upper lung of a nons...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Int Med Res
Glavni autori: Lin, Liping, Huang, Fuxi, Chen, Fang, He, Yan, Hu, Jiazhu, Cao, Xiaolong
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2018
Teme:
Case Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134637/
https://ncbi.nlm.nih.gov/pubmed/29310482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060517748262
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items